BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

7390 related articles for article (PubMed ID: 3129542)

  • 1. Differential in vitro effects of recombinant alpha-interferon and recombinant gamma-interferon alone or in combination on the expression of melanoma-associated surface antigens.
    Murray JL; Stuckey SE; Pillow JK; Rosenblum MG; Gutterman JU
    J Biol Response Mod; 1988 Apr; 7(2):152-61. PubMed ID: 3129542
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Effect of recombinant human fibroblast interferon and mezerein on growth, differentiation, immune interferon binding and tumor associated antigen expression in human melanoma cells.
    Fisher PB; Hermo H; Solowey WE; Dietrich MC; Edwalds GM; Weinstein IB; Langer JA; Pestka S; Giacomini P; Kusama M
    Anticancer Res; 1986; 6(4):765-74. PubMed ID: 2944474
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Comparative analysis of the priming effect of human interferon-gamma, -alpha, and -beta on synergism with muramyl dipeptide analog for anti-tumor expression of human blood monocytes.
    Utsugi T; Sone S
    J Immunol; 1986 Feb; 136(3):1117-22. PubMed ID: 3079797
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Regulation of the antigenic phenotype of human melanoma cells by recombinant interferons.
    Giacomini P; Gambari R; Barbieri R; Nisticò P; Tecce R; Pestka S; Gustafsson K; Natali PG; Fisher PB
    Anticancer Res; 1986; 6(5):877-84. PubMed ID: 2432832
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Immunochemical analysis of the modulation of human melanoma-associated antigens by DNA recombinant immune interferon.
    Giacomini P; Imberti L; Aguzzi A; Fisher PB; Trinchieri G; Ferrone S
    J Immunol; 1985 Oct; 135(4):2887-94. PubMed ID: 3928760
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Modulation by interferons of HLA antigen, high-molecular-weight melanoma associated antigen, and intercellular adhesion molecule 1 expression by cultured melanoma cells with different metastatic potential.
    Maio M; Gulwani B; Langer JA; Kerbel RS; Duigou GJ; Fisher PB; Ferrone S
    Cancer Res; 1989 Jun; 49(11):2980-7. PubMed ID: 2497970
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Differential modulation by recombinant immune interferon of the expression and shedding of HLA antigens and melanoma associated antigens by a melanoma cell line resistant to the antiproliferative activity of immune interferon.
    Ziai MR; Imberti L; Tongson A; Ferrone S
    Cancer Res; 1985 Nov; 45(11 Pt 2):5877-82. PubMed ID: 3931909
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Differential susceptibility to recombinant interferon-gamma-induced HLA-DQ antigen modulation among clones from a human metastatic melanoma.
    Anichini A; Castelli C; Sozzi G; Fossati G; Parmiani G
    J Immunol; 1988 Jan; 140(1):183-91. PubMed ID: 3121738
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Modulation by recombinant DNA leukocyte (alpha) and fibroblast (beta) interferons of the expression and shedding of HLA- and tumor-associated antigens by human melanoma cells.
    Giacomini P; Aguzzi A; Pestka S; Fisher PB; Ferrone S
    J Immunol; 1984 Sep; 133(3):1649-55. PubMed ID: 6747299
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Modulation of human melanoma cells by interleukin-4 and in combination with gamma-interferon or alpha-tumor necrosis factor.
    Hoon DS; Banez M; Okun E; Morton DL; Irie RF
    Cancer Res; 1991 Apr; 51(8):2002-8. PubMed ID: 1901239
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Classes I and II HLA and melanoma-associated antigen expression and modulation on melanoma cells isolated from primary and metastatic lesions.
    Taramelli D; Fossati G; Mazzocchi A; Delia D; Ferrone S; Parmiani G
    Cancer Res; 1986 Jan; 46(1):433-9. PubMed ID: 3079589
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Clinical and biological effects of intraperitoneal injections of recombinant interferon-gamma and recombinant interleukin 2 with or without tumor-infiltrating lymphocytes in patients with ovarian or peritoneal carcinoma.
    Freedman RS; Kudelka AP; Kavanagh JJ; Verschraegen C; Edwards CL; Nash M; Levy L; Atkinson EN; Zhang HZ; Melichar B; Patenia R; Templin S; Scott W; Platsoucas CD
    Clin Cancer Res; 2000 Jun; 6(6):2268-78. PubMed ID: 10873077
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Synergistic enhancement of class I major histocompatibility complex antigen expression in K562 cells induced by recombinant human interferon-gamma and tumor necrosis factor in combination.
    Takemura Y; Koide Y; Kawabata M; Kitajima S; Ohba C; Suzuki H; Sekiguchi S
    Exp Hematol; 1989 Aug; 17(7):795-9. PubMed ID: 2502422
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Differential effects of recombinant human leukocyte interferons on cell surface antigen expression.
    Greiner JW; Fisher PB; Pestka S; Schlom J
    Cancer Res; 1986 Oct; 46(10):4984-90. PubMed ID: 2944575
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Binding and cross-linking of recombinant mouse interferon-gamma to receptors in mouse leukemic L1210 cells; interferon-gamma internalization and receptor down-regulation.
    Wietzerbin J; Gaudelet C; Aguet M; Falcoff E
    J Immunol; 1986 Apr; 136(7):2451-5. PubMed ID: 2936825
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Antitumor effect of recombinant human interferon-beta and interferon-gamma in combination against human colon cancer cell line in vitro and in nude mice.
    Kondo H; Tanaka N; Naomoto Y; Orita K
    Jpn J Cancer Res; 1987 Nov; 78(11):1258-65. PubMed ID: 3121561
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The synergistic influence of human interferon-gamma and interferon-alpha on suppression of hematopoietic progenitor cells is additive with the enhanced sensitivity of these cells to inhibition by interferons at low oxygen tension in vitro.
    Broxmeyer HE; Cooper S; Rubin BY; Taylor MW
    J Immunol; 1985 Oct; 135(4):2502-6. PubMed ID: 3928752
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Distinct functional domains on the recombinant human immune interferon molecule.
    Ziai MR; Imberti L; Kobayashi M; Perussia B; Trinchieri G; Ferrone S
    Cancer Res; 1986 Dec; 46(12 Pt 1):6187-90. PubMed ID: 3096556
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Characterization of a monoclonal antibody-defined human melanoma-associated antigen susceptible to induction by immune interferon.
    Matsui M; Temponi M; Ferrone S
    J Immunol; 1987 Sep; 139(6):2088-95. PubMed ID: 3114385
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Recombinant alpha-interferon enhances tumor targeting of an antimelanoma monoclonal antibody in vivo.
    Murray JL; Zukiwski AA; Mujoo K; Rosenblum MG
    J Biol Response Mod; 1990 Dec; 9(6):556-63. PubMed ID: 2074442
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 370.